Type 2 Iodothyronine Deiodinase Is Expressed in Human Preadipocytes

被引:21
|
作者
Nomura, Emiko [1 ]
Toyoda, Nagaoki [1 ]
Harada, Azusa [1 ]
Nishimura, Kumiko [1 ]
Ukita, Chizuko [1 ]
Morimoto, Satoshi [1 ]
Kosaki, Atsushi [1 ]
Iwasaka, Toshiji [1 ]
Nishikawa, Mitsushige [1 ]
机构
[1] Kansai Med Univ, Dept Internal Med 2, Hirakata, Osaka 5731191, Japan
关键词
THYROID-HORMONE ACTION; BROWN ADIPOSE-TISSUE; GENE-EXPRESSION; MESSENGER-RNA; MUSCLE CELLS; ADIPOCYTES; TRIIODOTHYRONINE; DIFFERENTIATION; 5'-DEIODINASE; STIMULATION;
D O I
10.1089/thy.2010.0068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 2 iodothyronine deiodinase (D2) is an enzyme that catalyzes the production of triiodothyronine (T3) from thyroxine (T4) and plays a critical role in providing the local intracellular T3. Although D2 is highly expressed in brown adipose tissue, it was thought that D2 is hardly expressed in white adipose tissue. In the present study, we examined whether D2 is expressed in human preadipocytes, using human mesenteric and subcutaneous preadipocytes (HMPA and HSCPA, respectively). Methods: HMPA and HSCPA were purchased and cultured in the preadipocyte medium containing 10% fetal bovine serum. We measured D2 activity and mRNA level in HMPA and HSCPA incubated with or without dibutyryl cyclic adenosine monophosphate [(Bu)(2)cAMP]. Results: D2 activity and mRNA were detectable in human HMPA and HSCPA. The apparent Michaelis-Menten constant (K-m) value for T4 in HMPA was 2.1 +/- 0.2 nM, and the maximum velocity (V-max) value was 333.3 +/- 28.0 femtomols of I- released/mg protein/hour, respectively. On the other hand, the apparent K-m value for T4 in HSCPA was 2.0 +/- 0.2 nM and the V-max value was 91.2 +/- 8.7 femtomols of I- released/mg protein/hour, respectively. D2 activities in HMPA and HSCPA incubated with 1 mM (Bu)(2)cAMP for 24 hours were 7-fold (HMPA) and 3-fold (HSCPA) higher than those without (Bu)(2)cAMP, respectively. D2 mRNA levels in HMPA and HSCPA incubated with 1 mM (Bu)(2)cAMP for 3 hours were 10-fold (HMPA) and 5-fold (HSCPA) higher than those without (Bu)(2)cAMP, respectively. Conclusions: In the present study, we have clearly demonstrated that D2 activity and mRNA are present in the human preadipocytes from both mesenteric and subcutaneous adipose tissue. Our experiments are the first ones that identify human preadipocytes as one of the sources of T3 production.
引用
收藏
页码:305 / 310
页数:6
相关论文
共 50 条
  • [21] Thyroxine binding to type III iodothyronine deiodinase
    Craig A. Bayse
    Eric S. Marsan
    Jenna R. Garcia
    Alexis T. Tran-Thompson
    Scientific Reports, 10
  • [22] Inhibition of Type 1 Iodothyronine Deiodinase by Bisphenol A
    da Silva, Mauricio Martins
    Lima Goncalves, Carlos Frederico
    Miranda-Alves, Leandro
    Fortunato, Rodrigo Soares
    Carvalho, Denise P.
    Freitas Ferreira, Andrea Claudia
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (10) : 671 - 677
  • [23] Regulation of type 1 iodothyronine deiodinase by LXRα
    Sakane, Yoriko
    Kanamoto, Naotetsu
    Yamauchi, Ichiro
    Tagami, Tetsuya
    Morita, Yusuke
    Miura, Masako
    Sone, Masakatsu
    Yasoda, Akihiro
    Kimura, Takeshi
    Nakao, Kazuwa
    Inagaki, Nobuya
    PLOS ONE, 2017, 12 (06):
  • [24] Type II iodothyronine deiodinase is preferentially expressed in rainbow trout (Oncorhynchus mykiss) liver and gonads
    Sambroni, E
    Gutieres, S
    Cauty, C
    Guiguen, Y
    Breton, B
    Lareyre, JJ
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2001, 60 (03) : 338 - 350
  • [25] Thyroxine binding to type III iodothyronine deiodinase
    Bayse, Craig A.
    Marsan, Eric S.
    Garcia, Jenna R.
    Tran-Thompson, Alexis T.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Type 2 Iodothyronine Deiodinase in Skeletal Muscle: Effects of Hypothyroidism and Fasting
    Heemstra, Karen A.
    Soeters, Maarten R.
    Fliers, Eric
    Serlie, Mireille J.
    Burggraaf, Jacobus
    van Doorn, Martijn B.
    van der Klaauw, Agatha A.
    Romijn, Johannes A.
    Smit, Johannes W.
    Corssmit, Eleonora P.
    Visser, Theo J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (06): : 2144 - 2150
  • [27] Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy
    Wang, Yuan-Yuan
    Morimoto, Sachio
    Du, Cheng-Kun
    Lu, Qun-Wei
    Zhan, Dong-Yun
    Tsutsumi, Takaki
    Ide, Tomomi
    Miwa, Yosikazu
    Takahashi-Yanaga, Fumi
    Sasaguri, Toshiyuki
    CARDIOVASCULAR RESEARCH, 2010, 87 (04) : 636 - 646
  • [28] Type 2 iodothyronine deiodinase expression in the cochlea before the onset of hearing
    Campos-Barros, A
    Amma, LL
    Faris, JS
    Shailam, R
    Kelley, MW
    Forrest, D
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) : 1287 - 1292
  • [29] Expression and regulation of type 2 iodothyronine deiodinase in rat aorta media
    Yasuzawa-Amano, S
    Toyoda, N
    Maeda, A
    Kosaki, A
    Mori, Y
    Iwasaka, T
    Nishikawa, M
    ENDOCRINOLOGY, 2004, 145 (12) : 5638 - 5645
  • [30] CLONING AND INVITRO EXPRESSION OF THE HUMAN SELENOPROTEIN, TYPE-I IODOTHYRONINE DEIODINASE
    MANDEL, SJ
    BERRY, MJ
    KIEFFER, JD
    HARNEY, JW
    WARNE, RL
    LARSEN, PR
    CLINICAL RESEARCH, 1992, 40 (02): : A239 - A239